The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2024
This article has no abstract
Epistemonikos ID: e3f8de9fef928b490cc8f1aa3ddb0367c8ea42f9
First added on: Mar 21, 2025